Loading data...
Loading data...
The highest-currently-ranked healthcare stocks by StockIQ AI score, out of every stock analyzed on the site.
The healthcare sector spans very different risk profiles — from established pharmaceutical companies with stable cash flow, to research-stage biotech companies with no meaningful revenue that depend on regulatory approvals (like the FDA). StockIQ's Risk and Fundamental categories are especially sensitive to this distinction — a trial-stage biotech will tend to score higher risk than an established pharma company, even if its theoretical upside is larger.
This list is sorted by overall score (0-100) among companies classified in the healthcare sector. Worth remembering: regulatory events (FDA decisions, clinical trial results) can dramatically change a biotech's financial picture in a single announcement — something a historical-data-based score doesn't always capture until after the underlying data itself changes.
Not enough stocks currently meet this criteria to show a ranking.
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Because it lacks meaningful revenue and depends on unpredictable regulatory events — reflected in the Risk and Fundamental categories, even if its future potential is high.
The score updates when the system refreshes data for that stock (per the site's caching mechanism) — typically within hours, not instantly in real time for every event.
No — all fall under a single "Healthcare" sector here. The precise sub-industry (pharma, biotech, devices, healthcare services) appears on the individual stock page.